TheEdgeResearch
Home / Stocks / TGPHF

Together Pharma Ltd (TGPHF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.09 ▲ +0.00%
Market Cap
$18.5M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.47
52-Wk Range
0.09-0.09
CEO
Nissim Bracha
Country
IL
Currency
USD

Together Pharma Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ashkelon, IL. The stock last traded at $0.09, up 0.00% on the session, giving a market capitalisation of $18.5M. On trailing twelve-month figures it carries a trailing P/E of 19.40, a net margin of 1.7%. Its beta of 0.47 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
19.40
Price / Sales
0.38
Price / Book
0.90
EV / EBITDA
4.17
Gross margin
28.7%
Operating margin
13.9%
Net margin
1.7%
Return on equity
Debt / equity
1.24
Current ratio
1.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
145
IPO date
2022-09-19
Headquarters
Ashkelon, IL
About Together Pharma Ltd

Together Pharma Ltd, an Ashkelon, Israel-based company, along with its various subsidiaries, focuses on the cultivation, processing, storage, and widespread distribution of medicinal cannabis offerings throughout Israel.

Comparable companies

Together Pharma Ltd is most often compared with the following Healthcare names:

ATHJFBFFTFDIZTFGRAMFHMPSFHQDANXTTFPKANFRAMMFVNNYF
More research on TGPHF
TGPHF technical analysis TGPHF TheEdge Score Compare against peers
Open full interactive analysis & DCF →